Literature DB >> 23896296

Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone--a potential metal-protein attenuating compound (MPAC) for the treatment of Alzheimer's disease.

Leonardo Viana de Freitas1, Cecilia C P da Silva, Javier Ellena, Luiz Antônio Sodré Costa, Nicolás A Rey.   

Abstract

A comprehensive structural and vibrational study of the potential metal-protein attenuating compound 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone is reported. X-ray diffraction data, as well as FT-IR and Raman frequencies, were compared with the respective theoretical values obtained from DFT calculations. Theory agrees well with experiment. In this context, an attempt of total assignment concerning the FT-IR and Raman spectra of the title compound was performed, shedding new light on previous partial assignments published elsewhere.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; DFT calculations; Isoniazid; Vibrational spectroscopy; XRD

Mesh:

Substances:

Year:  2013        PMID: 23896296     DOI: 10.1016/j.saa.2013.06.105

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Aroylhydrazones constitute a promising class of 'metal-protein attenuating compounds' for the treatment of Alzheimer's disease: a proof-of-concept based on the study of the interactions between zinc(II) and pyridine-2-carboxaldehyde isonicotinoyl hydrazone.

Authors:  Daphne S Cukierman; Elio Accardo; Rosana Garrido Gomes; Anna De Falco; Marco C Miotto; Maria Clara Ramalho Freitas; Mauricio Lanznaster; Claudio O Fernández; Nicolás A Rey
Journal:  J Biol Inorg Chem       Date:  2018-08-25       Impact factor: 3.358

2.  5-((1H-imidazol-1-yl)methyl)quinolin-8-ol as potential antiviral SARS-CoV-2 candidate: Synthesis, crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies.

Authors:  Dhaybia Douche; Yusuf Sert; Silvia A Brandán; Ameed Ahmed Kawther; Bayram Bilmez; Necmi Dege; Ahmed El Louzi; Khalid Bougrin; Khalid Karrouchi; Banacer Himmi
Journal:  J Mol Struct       Date:  2021-01-27       Impact factor: 3.196

3.  Tridentate N-Acylhydrazones as Moderate Ligands for the Potential Management of Cognitive Decline Associated With Metal-Enhanced Neuroaggregopathies.

Authors:  Daphne S Cukierman; Nicolás A Rey
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.